NCT07606781 Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies
| NCT ID | NCT07606781 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Superior Hypogastric Plexus Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-05-23 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2026-05-23 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the analgesic effect of superior hypogastric plexus block combined with transversus abdominis plane block in abdominal hysterectomies.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * American Society of Anesthesiology (ASA) physical status I-II. * Undergoing abdominal hysterectomies under general anesthesia (GA). Exclusion Criteria: * History of allergies to local anesthetics. * Body mass index (BMI) \>35 kg/m2. * Opioid dependency. * Cognitive impairment. * Bleeding or coagulation disorders. * Psychiatric and neurological disorder. * Local infection at the site of injection. * Severe heart, lung, liver, and renal dysfunction.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07606781 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Superior Hypogastric Plexus Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07606781 currently recruiting?
Yes, NCT07606781 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07606781 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07606781 clinical trial?
NCT07606781 is sponsored by Tanta University. The trial plans to enroll 44 participants.